Agios Pharmaceuticals AGIO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's accounts payable?
- Agios Pharmaceuticals (AGIO) reported accounts payable of $13.75M in Q1 2026.
- How has Agios Pharmaceuticals's accounts payable changed year-over-year?
- Agios Pharmaceuticals's accounts payable increased by 0.2% year-over-year, from $13.73M to $13.75M.
- What is the long-term trend for Agios Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's accounts payable has grown at a 0.7% compound annual growth rate (CAGR), from $17.72M to $18.36M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.